This Is (Not) Spinal Tap

We’ve seen a rash of deals for all things spinal in recent weeks, from Stryker Corp.‘s (NYSE: SYK) $1.4 billion deal for K2M Group (NASDAQ: KTWO) to IZI Medical‘s acquisition of Benvenue Medical‘s vertebral augmentation systems. What’s the occasion? Well, it’s that time of year when the big medical conferences loom. The Society for Minimally […]

 

Health Care M&A Deals, Week Ending September 14, 2018

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in […]

 

DW Healthcare Partners Exits Rehab and Enters Behavioral Health

DW Healthcare Partners has had a busy summer, buying a healthcare staffing company and a behavioral health platform, then selling its rehabilitation business. In June, the firm announced its investment in Aequor Healthcare Services in Piscataway, New Jersey, the sixth investment made by DW Healthcare Partners Fund IV, LP. Aequor specializes in healthcare and clinical staffing […]

 

Welltok Strikes Again, Buying WellPass

Welltok, a portfolio company of New Enterprise Associates since 2013, has boosted its consumer health platform, CafeWell, with the acquisition of WellPass. WellPass was formed in 2017 through the merger of Sense Health and Voxiva. The latter worked with many large payers and organizations on mobile and digital health products. Sense Health focuses on Medicaid […]

 

Allergan Doubles Down on Aesthetics

September 14 was a big day for Allergan plc‘s (NYSE: AGN) medical aesthetics business. The company announced its acquisition of Bonti, Inc., a privately held clinical-stage biotech that develops novel, fast-acting neurotoxin programs for aesthetic and therapeutic applications. Later that same day, Allergan hosted a Medical Aesthetics Day in New York, at which its chief […]

Health Care M&A Deals, Week Ending September 7, 2018

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in […]

Summertime Sales from Novartis

It’s been a busy summer for Novartis AG (NYSE: NVS). The Swiss drug-maker has sold off a few assets, one at a loss. On August 31, Mylan NV (NYSE: MYL) acknowledged that it paid $463 million for Novartis’ cystic fibrosis products. Novartis sold the worldwide rights to commercialize its cystic fibrosis products TOBI Podhaler (tobramycin inhalation powder) […]